Erythropoietin may impair, not improve, cancer survival

Nat Med. 2003 Dec;9(12):1439. doi: 10.1038/nm1203-1439.
No abstract available

Publication types

  • News

MeSH terms

  • Anemia / drug therapy
  • Anemia / etiology
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / mortality
  • Cell Division / drug effects
  • Erythropoietin / adverse effects*
  • Female
  • Humans
  • Male
  • Neoplasms / blood supply
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / mortality
  • Neovascularization, Pathologic / etiology
  • Receptors, Erythropoietin / metabolism
  • Recombinant Proteins

Substances

  • Receptors, Erythropoietin
  • Recombinant Proteins
  • Erythropoietin